Empagliflozin and dapagliflozin decreased atrial monoamine oxidase expression and alleviated oxidative stress in overweight non-diabetic cardiac patients. - Ionică LN; Buriman DG; Lința AV; Șoșdean R; Lascu A; Streian CG; Feier HB; Petrescu L; Mozoș IM; Sturza A; Muntean DM (Molecular and cellular biochemistry, 2025)